期刊文献+

坦度螺酮合并文拉法辛治疗抑郁症的对照研究 被引量:1

The Control Study on the Treatment of Depressive Disorder by Tandospirone Combined with Venlafaxine
下载PDF
导出
摘要 目的探讨坦度螺酮联合文拉法辛对抑郁症患者的疗效。方法将60例抑郁症患者随机平分两组,分别为单用文拉法辛(文拉法辛组)及文拉法辛合用坦度螺酮(合用组),治疗4周。使用汉密尔顿抑郁量表(HAMD)在治疗1、2、4周进行评定。以副反应量表评定不良反应。结果合用组在起效时间、明显改善时间均较文拉法辛组快,HAMD分值下降较文拉法辛组更迅速。结论坦度螺酮联合文拉法辛治疗抑郁症患者疗效优于单用文拉法辛。 Objective To discuss the therapeutic effect of the treatment to the patients suffered from depressive disorder by tandospirone combined with venlafaxine. Methods 60 cases of depressive disorder were divided at random into 2 even groups. One group(the venlafaxine group) was treated by venlafaxine alone and the other one(the combined group) was treated by venlafaxine combined wth tandospirone. The duration of the treatments for each group was 4 weeks. The treatments were to be accessed by Hamilton depression scale(HAMD) at the first, the second and the fourth week. The adverse effect was accessed by treatment emergent symptom scale(TESS). Results The combined group was quicker than the venlafaxine group in the reacting time of the treatment and the time of remarkable improvement of pathogenetic conditions, and faster in the speed of how the HAMD value decreases. Conclusion The treatment by tandospirone combined with venlafaxine outweighs that by venlafaxine alone in its therapeutic effect to the patients suffered from depressive disorder.
作者 熊骊龙 侯荔
出处 《中国现代医生》 2009年第6期136-136,139,共2页 China Modern Doctor
关键词 文拉法辛 坦度螺酮 抑郁症 Venlafaxine Tandospirone Depressive disorder
  • 相关文献

参考文献6

二级参考文献32

  • 1肖水源.《社会支持评定量表》的理论基础与研究应用[J].临床精神医学杂志,1994,4(2):98-100. 被引量:4037
  • 2张明园.精神科量表评定手册.长沙:湖南科学技术出版社,1998.122-127. 被引量:1
  • 3[5]Murasaki M. Overview of serotonin 1A receptor selective agents in anxiety disorders - the developmental situation in Japan. Int Rev Psychiatry, 1995, 7:105~113 被引量:1
  • 4[6]Murasaki M, Miura S. Future of 5-HT1A receptor agonists (aryl-piperazine derivatives). Prog Neuro-Psychopharmacol &Biol Psychiatry, 1992, 16:833~845 被引量:1
  • 5[7]Matsumoto M, Yoshioka M. Possible involvment of serotonin receptors in anxiety disorders. Nippon Yakurigahu Zasshi, 2000,115 (Suppl.): S39~S44 被引量:1
  • 6[8]Shimizu H, Kariai N, Hirose A, et al. Interaction of SM-3997with serotonin receptors in rat brain. Jpn J Pharmacol, 1998,46:311~314 被引量:1
  • 7[9]Shimizu H, Tatsuno T, Tanaka H, et al. Serotonergic mechanism in anxiolytic effect of tandospirone in the vogel conflict test.Jpn J Pharmacol, 1992, 59:105~122 被引量:1
  • 8[10]Barradell LB, Fitton A. Tandospirone. CNC Drug, 1996, 5:147~153 被引量:1
  • 9[11]Lucki I. Behavioral studies of serotonin receptor agonists as antidepressant drug. J Clin Psychiatry, 1991, 52 (Suppl.): S24~S31 被引量:1
  • 10[13]Sumiyoshi T, Matsui M, Yamashita I, et al. The effect of tandospirone, a serotonin1A agonist, on memory function in schizophrenia. Bio Psychiatry, 2001, 49:861~868 被引量:1

共引文献176

同被引文献4

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部